已收盤 11-20 16:00:00 美东时间
-0.260
-10.20%
11月21日,Nasus Pharma(NSRX)收跌10.2%,报2.29美元,成交额7.87万美元,市值2682.44万美元。 行情数据 • 开盘价:2....
11-21 08:40
Nasus Pharma appoints Nir Sassi as CFO, bringing 25 years of experience in biopharmaceutical finance and capital markets. Sassi previously served as CFO of two Nasdaq-listed companies and will support Nasus as it advances its NS002 pivotal Phase 3 study and pre-commercial plans. The company expects to initiate the study in Q4 2026 and release topline data in Q1 2027. Sassi's expertise is expected to strengthen Nasus' financial and operational cap...
11-16 13:00
11月14日,Nasus Pharma(NSRX)收涨1.77%,报2.87美元,成交额1.34万美元,市值3374.8万美元。 行情数据 • 开盘价:2.9...
11-14 08:34
Nasus Pharma Ltd. announced that abstracts supporting its investigational intranasal epinephrine powder, NS002, for treating anaphylaxis, have been accepted for presentation at the 2026 ACAAI Annual Scientific Meeting in Phoenix, AZ. The abstract "Enhanced Absorption of Intranasal Powder Epinephrine (FMXIN002) after Single Dose in Adults with Allergic Rhinitis" will be presented orally by Dr. Michael Blaiss on November 14. Three additional poster...
11-10 13:00
11月7日,Nasus Pharma(NSRX)收跌3.09%,报2.82美元,成交额2.02万美元,市值3316.01万美元。 行情数据 • 开盘价:2.8...
11-07 08:30
今日重点评级关注:Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至118美元;Canaccord Genuity:维持Aclaris Therapeutics"买入"评级,目标价从10美元升至13美元
11-02 18:53
10月31日,Nasus Pharma(NSRX)收跌3.76%,报3.07美元,成交额1.55万美元,市值3596.13万美元。 行情数据 • 开盘价:3....
10-31 07:31
Maxim Group analyst Naz Rahman initiates coverage on Nasus Pharma (AMEX:NSRX) with a Buy rating and announces Price Target of $7.
10-30 21:32
10月27日,Nasus Pharma(NSRX)收平,报3.49美元,成交额5.26万美元,市值4088.16万美元。 行情数据 • 开盘价:3.41美元 ...
10-27 07:30
10月20-22日上海黄浦江畔,2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势,更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 07:37